APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omega-3 EPA and DHA Concentrates

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Omega-3 EPA and DHA Concentrates Market Outlook and Growth Opportunities 2026

24 December 2025202 pages

Choose your research edition.

Industry ResearchOmega-3 EPA and DHA Concentrates Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Omega-3 EPA and DHA Concentrates Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Omega-3 EPA and DHA Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omega-3 EPA and DHA Concentrates Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Omega-3 EPA and DHA Concentrates Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Omega-3 EPA and DHA Concentrates market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Omega-3 EPA and DHA Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Omega-3 EPA and DHA Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omega-3 EPA and DHA Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Omega-3 EPA and DHA Concentrates market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Omega-3 EPA and DHA Concentrates market include Skuny Bioscience, Yuwang Pharma, Xinzhou Marine Biological Products, Sinomega Biotech Engineering, KinOmega Biopharm, Renpu Pharmaceuticals, Jiangsu Auqi Marine Biotechnology, Huatai Phrama and BASF, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Omega-3 EPA and DHA Concentrates market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Omega-3 EPA and DHA Concentrates and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Omega-3 EPA and DHA Concentrates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Omega-3 EPA and DHA Concentrates market size, projected growth trends, production technologies, key applications, and end-use industries.

Omega-3 EPA and DHA Concentrates Segment by Company

Skuny Bioscience

Yuwang Pharma

Xinzhou Marine Biological Products

Sinomega Biotech Engineering

KinOmega Biopharm

Renpu Pharmaceuticals

Jiangsu Auqi Marine Biotechnology

Huatai Phrama

BASF

TASA

Solutex

Polaris

Pelagia (EPAX)

Omega Protein

Nu-Mega (Clover)

KD Pharma

Golden Omega

GC Rieber VivoMega

Croda

AlaskOmega (Wiley Companies)

Omega-3 EPA and DHA Concentrates Segment by Type

EPA

DHA

Omega-3 EPA and DHA Concentrates Segment by Application

Pet Food

Fortified Food and Beverages

Dietary Supplements

Infant Formula

Pharmaceuticals

Others

Omega-3 EPA and DHA Concentrates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Omega-3 EPA and DHA Concentrates status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Omega-3 EPA and DHA Concentrates market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Omega-3 EPA and DHA Concentrates significant trends, drivers, influence factors in global and regions.

6. To analyze Omega-3 EPA and DHA Concentrates competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega-3 EPA and DHA Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omega-3 EPA and DHA Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega-3 EPA and DHA Concentrates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Omega-3 EPA and DHA Concentrates market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omega-3 EPA and DHA Concentrates industry.

Chapter 3: Detailed analysis of Omega-3 EPA and DHA Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Omega-3 EPA and DHA Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Omega-3 EPA and DHA Concentrates in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Omega-3 EPA and DHA Concentrates Industry Trends Table 2. Omega-3 EPA and DHA Concentrates Industry Drivers Table 3. Omega-3 EPA and DHA Concentrates Industry Opportunities and Challenges Table 4. Omega-3 EPA and DHA Concentrates Industry Restraints Table 5. Global Omega-3 EPA and DHA Concentrates Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Omega-3 EPA and DHA Concentrates Revenue Share by Company (2021-2026) Table 7. Global Omega-3 EPA and DHA Concentrates Sales Volume by Company (t) & (2021-2026) Table 8. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Company (2021-2026) Table 9. Global Omega-3 EPA and DHA Concentrates Average Price (USD/t) of Company (2021-2026) Table 10. Global Omega-3 EPA and DHA Concentrates Company Ranking, (2024-2026) & (USD Million) Table 11. Global Omega-3 EPA and DHA Concentrates Key Company Manufacturing Base & Headquarters Table 12. Global Omega-3 EPA and DHA Concentrates Company, Product Type & Application Table 13. Global Omega-3 EPA and DHA Concentrates Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Omega-3 EPA and DHA Concentrates by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of EPA Table 18. Significant Companies of DHA Table 19. Global Omega-3 EPA and DHA Concentrates Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Omega-3 EPA and DHA Concentrates Sales Volume by Type (2021-2026) & (t) Table 21. Global Omega-3 EPA and DHA Concentrates Sales Volume by Type (2027-2032) & (t) Table 22. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Type (2021-2026) Table 23. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Type (2027-2032) Table 24. Global Omega-3 EPA and DHA Concentrates Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Omega-3 EPA and DHA Concentrates Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Omega-3 EPA and DHA Concentrates Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Type (2021-2026) Table 28. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pet Food Table 30. Significant Companies of Fortified Food and Beverages Table 31. Significant Companies of Dietary Supplements Table 32. Significant Companies of Infant Formula Table 33. Significant Companies of Pharmaceuticals Table 34. Significant Companies of Others Table 35. Global Omega-3 EPA and DHA Concentrates Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Omega-3 EPA and DHA Concentrates Sales Volume by Application (2021-2026) & (t) Table 37. Global Omega-3 EPA and DHA Concentrates Sales Volume by Application (2027-2032) & (t) Table 38. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Application (2021-2026) Table 39. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Application (2027-2032) Table 40. Global Omega-3 EPA and DHA Concentrates Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Omega-3 EPA and DHA Concentrates Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Omega-3 EPA and DHA Concentrates Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Application (2021-2026) Table 44. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Application (2027-2032) Table 45. Global Omega-3 EPA and DHA Concentrates Sales by Region: 2021 VS 2025 VS 2032 (t) Table 46. Global Omega-3 EPA and DHA Concentrates Sales by Region (2021-2026) & (t) Table 47. Global Omega-3 EPA and DHA Concentrates Sales Market Share by Region (2021-2026) Table 48. Global Omega-3 EPA and DHA Concentrates Sales by Region (2027-2032) & (t) Table 49. Global Omega-3 EPA and DHA Concentrates Sales Market Share by Region (2027-2032) Table 50. Global Omega-3 EPA and DHA Concentrates Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Omega-3 EPA and DHA Concentrates Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Region (2021-2026) Table 53. Global Omega-3 EPA and DHA Concentrates Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Region (2027-2032) Table 55. Global Omega-3 EPA and DHA Concentrates Market Average Price (USD/t) by Region (2021-2026) Table 56. Global Omega-3 EPA and DHA Concentrates Market Average Price (USD/t) by Region (2027-2032) Table 57. Global Omega-3 EPA and DHA Concentrates Sales by Country: 2021 VS 2025 VS 2032 (t) Table 58. Global Omega-3 EPA and DHA Concentrates Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Omega-3 EPA and DHA Concentrates Sales by Country (2021-2026) & (t) Table 60. Global Omega-3 EPA and DHA Concentrates Sales Market Share by Country (2021-2026) Table 61. Global Omega-3 EPA and DHA Concentrates Sales by Country (2027-2032) & (t) Table 62. Global Omega-3 EPA and DHA Concentrates Sales Market Share by Country (2027-2032) Table 63. Global Omega-3 EPA and DHA Concentrates Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Omega-3 EPA and DHA Concentrates Sales Value Market Share by Country (2021-2026) Table 65. Global Omega-3 EPA and DHA Concentrates Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Omega-3 EPA and DHA Concentrates Sales Value Market Share by Country (2027-2032) Table 67. Skuny Bioscience Company Information Table 68. Skuny Bioscience Business Overview Table 69. Skuny Bioscience Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Skuny Bioscience Omega-3 EPA and DHA Concentrates Product Portfolio Table 71. Skuny Bioscience Recent Development Table 72. Yuwang Pharma Company Information Table 73. Yuwang Pharma Business Overview Table 74. Yuwang Pharma Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Yuwang Pharma Omega-3 EPA and DHA Concentrates Product Portfolio Table 76. Yuwang Pharma Recent Development Table 77. Xinzhou Marine Biological Products Company Information Table 78. Xinzhou Marine Biological Products Business Overview Table 79. Xinzhou Marine Biological Products Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Xinzhou Marine Biological Products Omega-3 EPA and DHA Concentrates Product Portfolio Table 81. Xinzhou Marine Biological Products Recent Development Table 82. Sinomega Biotech Engineering Company Information Table 83. Sinomega Biotech Engineering Business Overview Table 84. Sinomega Biotech Engineering Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. Sinomega Biotech Engineering Omega-3 EPA and DHA Concentrates Product Portfolio Table 86. Sinomega Biotech Engineering Recent Development Table 87. KinOmega Biopharm Company Information Table 88. KinOmega Biopharm Business Overview Table 89. KinOmega Biopharm Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. KinOmega Biopharm Omega-3 EPA and DHA Concentrates Product Portfolio Table 91. KinOmega Biopharm Recent Development Table 92. Renpu Pharmaceuticals Company Information Table 93. Renpu Pharmaceuticals Business Overview Table 94. Renpu Pharmaceuticals Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Renpu Pharmaceuticals Omega-3 EPA and DHA Concentrates Product Portfolio Table 96. Renpu Pharmaceuticals Recent Development Table 97. Jiangsu Auqi Marine Biotechnology Company Information Table 98. Jiangsu Auqi Marine Biotechnology Business Overview Table 99. Jiangsu Auqi Marine Biotechnology Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Jiangsu Auqi Marine Biotechnology Omega-3 EPA and DHA Concentrates Product Portfolio Table 101. Jiangsu Auqi Marine Biotechnology Recent Development Table 102. Huatai Phrama Company Information Table 103. Huatai Phrama Business Overview Table 104. Huatai Phrama Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. Huatai Phrama Omega-3 EPA and DHA Concentrates Product Portfolio Table 106. Huatai Phrama Recent Development Table 107. BASF Company Information Table 108. BASF Business Overview Table 109. BASF Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. BASF Omega-3 EPA and DHA Concentrates Product Portfolio Table 111. BASF Recent Development Table 112. TASA Company Information Table 113. TASA Business Overview Table 114. TASA Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. TASA Omega-3 EPA and DHA Concentrates Product Portfolio Table 116. TASA Recent Development Table 117. Solutex Company Information Table 118. Solutex Business Overview Table 119. Solutex Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Solutex Omega-3 EPA and DHA Concentrates Product Portfolio Table 121. Solutex Recent Development Table 122. Polaris Company Information Table 123. Polaris Business Overview Table 124. Polaris Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 125. Polaris Omega-3 EPA and DHA Concentrates Product Portfolio Table 126. Polaris Recent Development Table 127. Pelagia (EPAX) Company Information Table 128. Pelagia (EPAX) Business Overview Table 129. Pelagia (EPAX) Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 130. Pelagia (EPAX) Omega-3 EPA and DHA Concentrates Product Portfolio Table 131. Pelagia (EPAX) Recent Development Table 132. Omega Protein Company Information Table 133. Omega Protein Business Overview Table 134. Omega Protein Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 135. Omega Protein Omega-3 EPA and DHA Concentrates Product Portfolio Table 136. Omega Protein Recent Development Table 137. Nu-Mega (Clover) Company Information Table 138. Nu-Mega (Clover) Business Overview Table 139. Nu-Mega (Clover) Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 140. Nu-Mega (Clover) Omega-3 EPA and DHA Concentrates Product Portfolio Table 141. Nu-Mega (Clover) Recent Development Table 142. KD Pharma Company Information Table 143. KD Pharma Business Overview Table 144. KD Pharma Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 145. KD Pharma Omega-3 EPA and DHA Concentrates Product Portfolio Table 146. KD Pharma Recent Development Table 147. Golden Omega Company Information Table 148. Golden Omega Business Overview Table 149. Golden Omega Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 150. Golden Omega Omega-3 EPA and DHA Concentrates Product Portfolio Table 151. Golden Omega Recent Development Table 152. GC Rieber VivoMega Company Information Table 153. GC Rieber VivoMega Business Overview Table 154. GC Rieber VivoMega Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 155. GC Rieber VivoMega Omega-3 EPA and DHA Concentrates Product Portfolio Table 156. GC Rieber VivoMega Recent Development Table 157. Croda Company Information Table 158. Croda Business Overview Table 159. Croda Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 160. Croda Omega-3 EPA and DHA Concentrates Product Portfolio Table 161. Croda Recent Development Table 162. AlaskOmega (Wiley Companies) Company Information Table 163. AlaskOmega (Wiley Companies) Business Overview Table 164. AlaskOmega (Wiley Companies) Omega-3 EPA and DHA Concentrates Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 165. AlaskOmega (Wiley Companies) Omega-3 EPA and DHA Concentrates Product Portfolio Table 166. AlaskOmega (Wiley Companies) Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Omega-3 EPA and DHA Concentrates Distributors List Table 170. Omega-3 EPA and DHA Concentrates Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Omega-3 EPA and DHA Concentrates Product Image Figure 2. Global Omega-3 EPA and DHA Concentrates Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omega-3 EPA and DHA Concentrates Sales Value (2021-2032) & (US$ Million) Figure 4. Global Omega-3 EPA and DHA Concentrates Sales (2021-2032) & (t) Figure 5. Global Omega-3 EPA and DHA Concentrates Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Omega-3 EPA and DHA Concentrates Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. EPA Image Figure 10. DHA Image Figure 11. Global Omega-3 EPA and DHA Concentrates Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Omega-3 EPA and DHA Concentrates Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Type (2021-2032) Figure 14. Global Omega-3 EPA and DHA Concentrates Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Omega-3 EPA and DHA Concentrates Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Type (2021-2032) Figure 17. Pet Food Image Figure 18. Fortified Food and Beverages Image Figure 19. Dietary Supplements Image Figure 20. Infant Formula Image Figure 21. Pharmaceuticals Image Figure 22. Others Image Figure 23. Global Omega-3 EPA and DHA Concentrates Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 24. Global Omega-3 EPA and DHA Concentrates Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Application (2021-2032) Figure 26. Global Omega-3 EPA and DHA Concentrates Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Omega-3 EPA and DHA Concentrates Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Application (2021-2032) Figure 29. Global Omega-3 EPA and DHA Concentrates Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 30. Global Omega-3 EPA and DHA Concentrates Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Omega-3 EPA and DHA Concentrates Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Omega-3 EPA and DHA Concentrates Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Omega-3 EPA and DHA Concentrates Sales Value (2021-2032) & (US$ Million) Figure 34. North America Omega-3 EPA and DHA Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Omega-3 EPA and DHA Concentrates Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Omega-3 EPA and DHA Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Omega-3 EPA and DHA Concentrates Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Omega-3 EPA and DHA Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Omega-3 EPA and DHA Concentrates Sales Value (2021-2032) & (US$ Million) Figure 40. South America Omega-3 EPA and DHA Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Omega-3 EPA and DHA Concentrates Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Omega-3 EPA and DHA Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Omega-3 EPA and DHA Concentrates Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Omega-3 EPA and DHA Concentrates Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • EPA
  • DHA
Applications
  • Pet Food
  • Fortified Food and Beverages
  • Dietary Supplements
  • Infant Formula
  • Pharmaceuticals
  • Others
Companies covered
  • Skuny Bioscience
  • Yuwang Pharma
  • Xinzhou Marine Biological Products
  • Sinomega Biotech Engineering
  • KinOmega Biopharm
  • Renpu Pharmaceuticals
  • Jiangsu Auqi Marine Biotechnology
  • Huatai Phrama
  • BASF
  • TASA
  • Solutex
  • Polaris
  • Pelagia (EPAX)
  • Omega Protein
  • Nu-Mega (Clover)
  • KD Pharma
  • Golden Omega
  • GC Rieber VivoMega
  • Croda
  • AlaskOmega (Wiley Companies)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Omega-3 EPA and DHA Concentrates Sales Value (2021-2032)
  4. 1.2.2 Global Omega-3 EPA and DHA Concentrates Sales Volume (2021-2032)
  5. 1.2.3 Global Omega-3 EPA and DHA Concentrates Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Omega-3 EPA and DHA Concentrates Market Dynamics
  1. 2.1 Omega-3 EPA and DHA Concentrates Industry Trends
  2. 2.2 Omega-3 EPA and DHA Concentrates Industry Drivers
  3. 2.3 Omega-3 EPA and DHA Concentrates Industry Opportunities and Challenges
  4. 2.4 Omega-3 EPA and DHA Concentrates Industry Restraints
3 Omega-3 EPA and DHA Concentrates Market by Company
  1. 3.1 Global Omega-3 EPA and DHA Concentrates Company Revenue Ranking in 2025
  2. 3.2 Global Omega-3 EPA and DHA Concentrates Revenue by Company (2021-2026)
  3. 3.3 Global Omega-3 EPA and DHA Concentrates Sales Volume by Company (2021-2026)
  4. 3.4 Global Omega-3 EPA and DHA Concentrates Average Price by Company (2021-2026)
  5. 3.5 Global Omega-3 EPA and DHA Concentrates Company Ranking (2024-2026)
  6. 3.6 Global Omega-3 EPA and DHA Concentrates Company Manufacturing Base and Headquarters
  7. 3.7 Global Omega-3 EPA and DHA Concentrates Company Product Type and Application
  8. 3.8 Global Omega-3 EPA and DHA Concentrates Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Omega-3 EPA and DHA Concentrates Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Omega-3 EPA and DHA Concentrates Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Omega-3 EPA and DHA Concentrates Market by Type
  1. 4.1 Omega-3 EPA and DHA Concentrates Type Introduction
  2. 4.1.1 EPA
  3. 4.1.2 DHA
  4. 4.2 Global Omega-3 EPA and DHA Concentrates Sales Volume by Type
  5. 4.2.1 Global Omega-3 EPA and DHA Concentrates Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Omega-3 EPA and DHA Concentrates Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Omega-3 EPA and DHA Concentrates Sales Value by Type
  9. 4.3.1 Global Omega-3 EPA and DHA Concentrates Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Omega-3 EPA and DHA Concentrates Sales Value by Type (2021-2032)
  11. 4.3.3 Global Omega-3 EPA and DHA Concentrates Sales Value Share by Type (2021-2032)
5 Omega-3 EPA and DHA Concentrates Market by Application
  1. 5.1 Omega-3 EPA and DHA Concentrates Application Introduction
  2. 5.1.1 Pet Food
  3. 5.1.2 Fortified Food and Beverages
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Infant Formula
  6. 5.1.5 Pharmaceuticals
  7. 5.1.6 Others
  8. 5.2 Global Omega-3 EPA and DHA Concentrates Sales Volume by Application
  9. 5.2.1 Global Omega-3 EPA and DHA Concentrates Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Omega-3 EPA and DHA Concentrates Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Omega-3 EPA and DHA Concentrates Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Omega-3 EPA and DHA Concentrates Sales Value by Application
  13. 5.3.1 Global Omega-3 EPA and DHA Concentrates Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Omega-3 EPA and DHA Concentrates Sales Value by Application (2021-2032)
  15. 5.3.3 Global Omega-3 EPA and DHA Concentrates Sales Value Share by Application (2021-2032)
6 Omega-3 EPA and DHA Concentrates Regional Sales and Value Analysis
  1. 6.1 Global Omega-3 EPA and DHA Concentrates Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Omega-3 EPA and DHA Concentrates Sales by Region (2021-2032)
  3. 6.2.1 Global Omega-3 EPA and DHA Concentrates Sales by Region: 2021-2026
  4. 6.2.2 Global Omega-3 EPA and DHA Concentrates Sales by Region (2027-2032)
  5. 6.3 Global Omega-3 EPA and DHA Concentrates Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Omega-3 EPA and DHA Concentrates Sales Value by Region (2021-2032)
  7. 6.4.1 Global Omega-3 EPA and DHA Concentrates Sales Value by Region: 2021-2026
  8. 6.4.2 Global Omega-3 EPA and DHA Concentrates Sales Value by Region (2027-2032)
  9. 6.5 Global Omega-3 EPA and DHA Concentrates Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Omega-3 EPA and DHA Concentrates Sales Value (2021-2032)
  12. 6.6.2 North America Omega-3 EPA and DHA Concentrates Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Omega-3 EPA and DHA Concentrates Sales Value (2021-2032)
  15. 6.7.2 Europe Omega-3 EPA and DHA Concentrates Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Omega-3 EPA and DHA Concentrates Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Omega-3 EPA and DHA Concentrates Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Omega-3 EPA and DHA Concentrates Sales Value (2021-2032)
  21. 6.9.2 South America Omega-3 EPA and DHA Concentrates Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Omega-3 EPA and DHA Concentrates Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Omega-3 EPA and DHA Concentrates Sales Value Share by Country, 2025 VS 2032
7 Omega-3 EPA and DHA Concentrates Country-level Sales and Value Analysis
  1. 7.1 Global Omega-3 EPA and DHA Concentrates Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Omega-3 EPA and DHA Concentrates Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Omega-3 EPA and DHA Concentrates Sales by Country (2021-2032)
  4. 7.3.1 Global Omega-3 EPA and DHA Concentrates Sales by Country (2021-2026)
  5. 7.3.2 Global Omega-3 EPA and DHA Concentrates Sales by Country (2027-2032)
  6. 7.4 Global Omega-3 EPA and DHA Concentrates Sales Value by Country (2021-2032)
  7. 7.4.1 Global Omega-3 EPA and DHA Concentrates Sales Value by Country (2021-2026)
  8. 7.4.2 Global Omega-3 EPA and DHA Concentrates Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Omega-3 EPA and DHA Concentrates Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Omega-3 EPA and DHA Concentrates Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Omega-3 EPA and DHA Concentrates Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Skuny Bioscience
  2. 8.1.1 Skuny Bioscience Company Information
  3. 8.1.2 Skuny Bioscience Business Overview
  4. 8.1.3 Skuny Bioscience Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Skuny Bioscience Omega-3 EPA and DHA Concentrates Product Portfolio
  6. 8.1.5 Skuny Bioscience Recent Developments
  7. 8.2 Yuwang Pharma
  8. 8.2.1 Yuwang Pharma Company Information
  9. 8.2.2 Yuwang Pharma Business Overview
  10. 8.2.3 Yuwang Pharma Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yuwang Pharma Omega-3 EPA and DHA Concentrates Product Portfolio
  12. 8.2.5 Yuwang Pharma Recent Developments
  13. 8.3 Xinzhou Marine Biological Products
  14. 8.3.1 Xinzhou Marine Biological Products Company Information
  15. 8.3.2 Xinzhou Marine Biological Products Business Overview
  16. 8.3.3 Xinzhou Marine Biological Products Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Xinzhou Marine Biological Products Omega-3 EPA and DHA Concentrates Product Portfolio
  18. 8.3.5 Xinzhou Marine Biological Products Recent Developments
  19. 8.4 Sinomega Biotech Engineering
  20. 8.4.1 Sinomega Biotech Engineering Company Information
  21. 8.4.2 Sinomega Biotech Engineering Business Overview
  22. 8.4.3 Sinomega Biotech Engineering Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sinomega Biotech Engineering Omega-3 EPA and DHA Concentrates Product Portfolio
  24. 8.4.5 Sinomega Biotech Engineering Recent Developments
  25. 8.5 KinOmega Biopharm
  26. 8.5.1 KinOmega Biopharm Company Information
  27. 8.5.2 KinOmega Biopharm Business Overview
  28. 8.5.3 KinOmega Biopharm Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 KinOmega Biopharm Omega-3 EPA and DHA Concentrates Product Portfolio
  30. 8.5.5 KinOmega Biopharm Recent Developments
  31. 8.6 Renpu Pharmaceuticals
  32. 8.6.1 Renpu Pharmaceuticals Company Information
  33. 8.6.2 Renpu Pharmaceuticals Business Overview
  34. 8.6.3 Renpu Pharmaceuticals Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Renpu Pharmaceuticals Omega-3 EPA and DHA Concentrates Product Portfolio
  36. 8.6.5 Renpu Pharmaceuticals Recent Developments
  37. 8.7 Jiangsu Auqi Marine Biotechnology
  38. 8.7.1 Jiangsu Auqi Marine Biotechnology Company Information
  39. 8.7.2 Jiangsu Auqi Marine Biotechnology Business Overview
  40. 8.7.3 Jiangsu Auqi Marine Biotechnology Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Auqi Marine Biotechnology Omega-3 EPA and DHA Concentrates Product Portfolio
  42. 8.7.5 Jiangsu Auqi Marine Biotechnology Recent Developments
  43. 8.8 Huatai Phrama
  44. 8.8.1 Huatai Phrama Company Information
  45. 8.8.2 Huatai Phrama Business Overview
  46. 8.8.3 Huatai Phrama Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Huatai Phrama Omega-3 EPA and DHA Concentrates Product Portfolio
  48. 8.8.5 Huatai Phrama Recent Developments
  49. 8.9 BASF
  50. 8.9.1 BASF Company Information
  51. 8.9.2 BASF Business Overview
  52. 8.9.3 BASF Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BASF Omega-3 EPA and DHA Concentrates Product Portfolio
  54. 8.9.5 BASF Recent Developments
  55. 8.10 TASA
  56. 8.10.1 TASA Company Information
  57. 8.10.2 TASA Business Overview
  58. 8.10.3 TASA Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 TASA Omega-3 EPA and DHA Concentrates Product Portfolio
  60. 8.10.5 TASA Recent Developments
  61. 8.11 Solutex
  62. 8.11.1 Solutex Company Information
  63. 8.11.2 Solutex Business Overview
  64. 8.11.3 Solutex Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Solutex Omega-3 EPA and DHA Concentrates Product Portfolio
  66. 8.11.5 Solutex Recent Developments
  67. 8.12 Polaris
  68. 8.12.1 Polaris Company Information
  69. 8.12.2 Polaris Business Overview
  70. 8.12.3 Polaris Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Polaris Omega-3 EPA and DHA Concentrates Product Portfolio
  72. 8.12.5 Polaris Recent Developments
  73. 8.13 Pelagia (EPAX)
  74. 8.13.1 Pelagia (EPAX) Company Information
  75. 8.13.2 Pelagia (EPAX) Business Overview
  76. 8.13.3 Pelagia (EPAX) Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Pelagia (EPAX) Omega-3 EPA and DHA Concentrates Product Portfolio
  78. 8.13.5 Pelagia (EPAX) Recent Developments
  79. 8.14 Omega Protein
  80. 8.14.1 Omega Protein Company Information
  81. 8.14.2 Omega Protein Business Overview
  82. 8.14.3 Omega Protein Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Omega Protein Omega-3 EPA and DHA Concentrates Product Portfolio
  84. 8.14.5 Omega Protein Recent Developments
  85. 8.15 Nu-Mega (Clover)
  86. 8.15.1 Nu-Mega (Clover) Company Information
  87. 8.15.2 Nu-Mega (Clover) Business Overview
  88. 8.15.3 Nu-Mega (Clover) Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Nu-Mega (Clover) Omega-3 EPA and DHA Concentrates Product Portfolio
  90. 8.15.5 Nu-Mega (Clover) Recent Developments
  91. 8.16 KD Pharma
  92. 8.16.1 KD Pharma Company Information
  93. 8.16.2 KD Pharma Business Overview
  94. 8.16.3 KD Pharma Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 KD Pharma Omega-3 EPA and DHA Concentrates Product Portfolio
  96. 8.16.5 KD Pharma Recent Developments
  97. 8.17 Golden Omega
  98. 8.17.1 Golden Omega Company Information
  99. 8.17.2 Golden Omega Business Overview
  100. 8.17.3 Golden Omega Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Golden Omega Omega-3 EPA and DHA Concentrates Product Portfolio
  102. 8.17.5 Golden Omega Recent Developments
  103. 8.18 GC Rieber VivoMega
  104. 8.18.1 GC Rieber VivoMega Company Information
  105. 8.18.2 GC Rieber VivoMega Business Overview
  106. 8.18.3 GC Rieber VivoMega Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 GC Rieber VivoMega Omega-3 EPA and DHA Concentrates Product Portfolio
  108. 8.18.5 GC Rieber VivoMega Recent Developments
  109. 8.19 Croda
  110. 8.19.1 Croda Company Information
  111. 8.19.2 Croda Business Overview
  112. 8.19.3 Croda Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Croda Omega-3 EPA and DHA Concentrates Product Portfolio
  114. 8.19.5 Croda Recent Developments
  115. 8.20 AlaskOmega (Wiley Companies)
  116. 8.20.1 AlaskOmega (Wiley Companies) Company Information
  117. 8.20.2 AlaskOmega (Wiley Companies) Business Overview
  118. 8.20.3 AlaskOmega (Wiley Companies) Omega-3 EPA and DHA Concentrates Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 AlaskOmega (Wiley Companies) Omega-3 EPA and DHA Concentrates Product Portfolio
  120. 8.20.5 AlaskOmega (Wiley Companies) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Omega-3 EPA and DHA Concentrates Value Chain Analysis
  2. 9.1.1 Omega-3 EPA and DHA Concentrates Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Omega-3 EPA and DHA Concentrates Sales Mode & Process
  6. 9.2 Omega-3 EPA and DHA Concentrates Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Omega-3 EPA and DHA Concentrates Distributors
  9. 9.2.3 Omega-3 EPA and DHA Concentrates Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst